Loading...

Cannara Biotech Inc.

LOVFF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$1.36
$-0.03(-2.44%)
U.S. Market opens in 14h 23m

Cannara Biotech Inc. (LOVFF) Stock Overview

Explore Cannara Biotech Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap130.1M
P/E Ratio14.80
EPS (TTM)$0.08
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$1.31
3 Months$1.38
1 Year Target$1.95

LOVFF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cannara Biotech Inc. (LOVFF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.53, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.95.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 14.80 and a market capitalization of 130.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.58%
5-Day Change
-2.30%
1-Month Change
4.46%
3-Month Change
2.11%
6-Month Change
11.31%
Year-to-Date (YTD) Change
6.93%
1-Year Change
48.82%
3-Year Change
134.14%
5-Year Change
21.25%
All-Time (Max) Change
-24.13%

Contact Information

https://cannara.ca
514-543-4200
333 Decarie Blvd., Saint-Laurent, QC, H4N 3M9

Company Facts

461 Employees
IPO DateJan 18, 2019
CountryCA
Actively Trading

Frequently Asked Questions